Dexrazoxane Intravenous and Rituximab and hyaluronidase human, recombinant Subcutaneous
Determining the interaction of Dexrazoxane Intravenous and Rituximab and hyaluronidase human, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Hyaluronidase and rituximab, Rituximab and Hyaluronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Rituximab Intravenous
- Dexrazoxane Intravenous-Riva-Amoxicillin
- Dexrazoxane Intravenous-Rivaroxaban
- Dexrazoxane Intravenous-Rivastigmine
- Dexrazoxane Intravenous-Rivastigmine Capsules
- Dexrazoxane Intravenous-Rivastigmine Oral Solution
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Dextenza Insert
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Dextenza intraocular
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Dextran 40
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Dextran 70 6% in 5% Dextrose high molecular weight
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Dextran 75
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Dextran high molecular weight